Le Lézard
Classified in: Health, Business
Subject: TNM

Riccobene Associates Family Dentistry is Bringing Smiles to the Oxford Community


OXFORD, N.C., Jan. 7, 2019 /PRNewswire-PRWeb/ -- Riccobene Associates Family Dentistry, North Carolina's premier multi-specialty dental practice, has announced their acquisition of Highland Family Dentistry in Oxford on January 2nd, 2019. Riccobene Associates, based out of the Research Triangle region, is pleased to offer the highest standard of dental care to their new neighbors in the Oxford community at 111 East Industry Drive, Oxford, NC 27565.

"Dr. McNeal and the Highland Dentistry team have built a very special office with a great patient base," Dr. Michael Riccobene said. "We will continue to provide the excellent care the patients are already accustomed to, as well as implement some our best clinical and management practices to improve the overall employee and patient experience. We will be Stronger Together!"

The Oxford office provides a comprehensive selection of treatment options including general dentistry, cosmetic, implant, surgery and restorative treatment. Riccobene Associates accepts dental insurance; those without dental insurance will have access to an affordable in-house dental membership plan and patient financing.

Riccobene Associates Family Dentistry, founded in 2000 by Dr. Michael Riccobene, continues to focus on providing high-quality, patient-centered care through the use of state-of-the-art dental equipment and facilities. For more than 18 years, the company has earned numerous "Favorite Family Dentist" awards throughout the Triangle area in publications such as Cary Magazine and Carolina Parent. Riccobene Associates was named one of the 50 Best Places to Work in the Triangle last year and was recently recognized as a Fast 50 Company by the Triangle Business Journal. For more information or to request an appointment, please visit http://www.BrushAndFloss.com.

 

SOURCE Riccobene Associates Family Dentistry


These press releases may also interest you

at 08:25
NOVA LEAP HEALTH CORP. ("Nova Leap" or "the Company"), a growing home health care organization, is pleased to announce that it has executed a definitive agreement (the "Agreement"), dated April 25, 2024, to acquire a home care services company ("the...

at 08:20
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya's Scientific Advisory...

at 08:19
Nitto Denko Avecia Inc. and Nitto Denko Avecia Pharma Services (Nitto Avecia), a global leader in contract development and manufacturing of oligonucleotides for the therapeutic market announced today that Tammy Cooper will be appointed President of...

at 08:05
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...

at 08:05
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (MDNAF: OTCQB), a clinical-stage immunotherapy company focused on the development of engineered cytokines, today announced a CA$20 million investment by RA Capital Management, a multi-stage...

at 08:02
Sobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for the treatment and prevention of bleeds and perioperative...



News published on and distributed by: